186 related articles for article (PubMed ID: 12446514)
1. The changed image of botulinum toxin.
Misra VP
BMJ; 2002 Nov; 325(7374):1188. PubMed ID: 12446514
[No Abstract] [Full Text] [Related]
2. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
3. Comparison of botulinum toxins A and B in the treatment of facial rhytides.
Sadick NS; Matarasso SL
Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for achalasia: to be or not to be?
Castell DO; Katzka DA
Gastroenterology; 1996 May; 110(5):1650-2. PubMed ID: 8613076
[No Abstract] [Full Text] [Related]
5. Cosmetic botulinum toxin injections.
Carter SR; Seiff SR
Int Ophthalmol Clin; 1997; 37(3):69-79. PubMed ID: 9279643
[No Abstract] [Full Text] [Related]
6. Botox and Dysport are distinct.
Madaliński M
Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924
[No Abstract] [Full Text] [Related]
7. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
8. [Botulinum toxin in the treatment of spasticity].
Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
[No Abstract] [Full Text] [Related]
9. Botulinum toxin in migraine.
Erbguth F; Brittner W; Fogel W; Hefter H; Herting B; von Lindern JJ; Umstadt HE
J Neurol; 2004 Feb; 251 Suppl 1():I31-2. PubMed ID: 14991340
[No Abstract] [Full Text] [Related]
10. Botulinum toxin type A injection for hyperfunctional facial lines.
Keen MS; Khosh MM
Laryngoscope; 1995 Oct; 105(10):1134-7. PubMed ID: 7564848
[No Abstract] [Full Text] [Related]
11. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
12. Botulinum toxin: a poison transformed into a versatile tool.
Mahajan S; Srivastava V
Eur J Esthet Dent; 2010; 5(4):327-9. PubMed ID: 21069104
[No Abstract] [Full Text] [Related]
13. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type B (Myobloc).
Baumann L; Black L
Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
[TBL] [Abstract][Full Text] [Related]
15. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
16. The use of botulinum A toxin to ameliorate facial kinetic frown lines.
Foster JA; Barnhorst D; Papay F; Oh PM; Wulc AE
Ophthalmology; 1996 Apr; 103(4):618-22. PubMed ID: 8618761
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin products overview.
Carruthers A; Carruthers J
Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxins. Introduction.
Klein AW
Semin Cutan Med Surg; 2001 Jun; 20(2):69-70. PubMed ID: 11474746
[No Abstract] [Full Text] [Related]
19. Implications of botulinum toxin injection of the brow.
Lackey JN; Norton SA
J Am Acad Dermatol; 2006 May; 54(5):921-2. PubMed ID: 16635690
[No Abstract] [Full Text] [Related]
20. The role of clostridium botulinum: a neurotoxin in clinical dermatology.
Matarasso SL
West J Med; 1998 Oct; 169(4):226. PubMed ID: 9795588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
